Skip to product information
1 of 1

Anti-SLC34A2 (Lifastuzumab) -MC-Vc-PAB-SN38

Anti-SLC34A2 (Lifastuzumab) -MC-Vc-PAB-SN38

Size

SKU:QM-0010055

Price on request
Quantity

Request quote or documents

View full details
  • Description

    Anti-SLC34A2 (Lifastuzumab) -MC-Vc-PAB-SN38 is an antibody-drug conjugate (ADC) consisting of the humanized anti-SLC34A2 (sodium-dependent phosphate transporter 2) antibody Lifastuzumab conjugated to the linker Mc-VC-PAB and the topoisomerase I inhibitor SN38 (HY-13704). The ADC toxic molecule and linker part are Mc-VC-PAB-SN38 (HY-131057). Anti-SLC34A2 (Lifastuzumab) -MC-Vc-PAB-SN38 can be used in cancer research[1][2].

  • Smiles

    [Anti-SLC34A2(Lifastuzumab)-MC-Vc-PAB-SN38]

  • Target

    Antibody-Drug Conjugates (ADCs) ; Sodium Channel; Topoisomerase

  • Isoform

    Topo I

  • Shipping Conditions

    Room temperature

Your cart
Variant Variant total Quantity Price Variant total
1 EachQM-0010055
1 EachQM-0010055
Regular price
£0.00
Sale price
£0.00/ea
£0.00
Regular price
£0.00
Sale price
£0.00/ea
£0.00

Anti-SLC34A2 (Lifastuzumab) -MC-Vc-PAB-SN38

Anti-SLC34A2 (Lifastuzumab) -MC-Vc-PAB-SN38 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.